Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Redox processes in neurodegenerative disease involving reactive oxygen species.
[Clinical and epidemiological aspects of multiple sclerosis in the Moscow region.]
Fiber density index in the evaluation of the spinal cord in patients with multiple sclerosis.
Use of engineered bone marrow stem cells to deliver brain derived neurotrophic factor under the control of a tetracycline sensitive response element in experimental allergic encephalomyelitis.
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance.
Duloxetine for the Treatment of Overactive Bladder Syndrome in Multiple Sclerosis: A Pilot Study.
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.
Regulation of DM-20 mRNA expression and intracellular translocation of glutathione-S-transferase pi isoform during oligodendrocyte differentiation in the adult rat spinal cord.
Multiple sclerosis guideline production takes off.
Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics.
Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading.
Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis.
Source of iron overload in multiple sclerosis.
Smoking increases the risk of multiple sclerosis in Queensland, Australia.
Endothelial microparticles interact with and support the proliferation of T cells.
Strengths and limitations of microarray-based phenotype prediction: Lessons learned from the IMPROVER Diagnostic Signature Challenge.
2nd International Symposium on Gait and Balance in Multiple Sclerosis: interventions for gait and balance in MS.
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
The CD27 and CD70 Costimulatory Pathway Inhibits Effector Function of T Helper 17 Cells and Attenuates Associated Autoimmunity.
Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Multiple sclerosis decreases explicit counterfactual processing and risk taking in decision making.
Clinical use of brain volumetry.
Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge.
Hospitalization rates and discharge status in multiple sclerosis.
Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis.

Pages